COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents
Public ClinicalTrials.gov record NCT04542395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multilevel Participatory Intervention to Reduce Barriers and Promote Social and Behavioral Facilitators of COVID-19 Testing Among African Americans and Latinx Public Housing Residents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.
Study identification
- NCT ID
- NCT04542395
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2023
- Primary completion
- Nov 29, 2025
- Completion
- Nov 29, 2025
- Last update posted
- Aug 18, 2022
2023 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Housing Authority of Clty of Los Angeles | Los Angeles | California | 90059 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Coronavirus trials
Other public records listing Coronavirus. Sorted by last update posted; newest first. Not a recommendation.
- NCT04568148: COVID-19 Biorepository Active, not recruiting
- NCT04367857: ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers Recruiting
- NCT07221097: Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses Recruiting
- NCT04772170: Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies Recruiting
- NCT05868239: Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study Recruiting
- NCT04359836: A Study to Explore the Role of Gut Flora in COVID-19 Infection Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04542395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04542395 live on ClinicalTrials.gov.